A Symptom-Based Algorithm for Rapid Clinical Diagnosis of COVID-19 in Adults With High-Risk Exposure

Shinji Inaba1,2,3, Shuntaro Ikeda1, Naoki Tsuda4

  • 1Department of Cardiology, Pulmonology, Hypertension, and Nephrology, Ehime University Graduate School of Medicine, Toon, JPN.

Cureus
|September 10, 2025
PubMed

Insights

A new symptom-based algorithm aids in diagnosing coronavirus disease 2019 (COVID-19) in high-risk individuals without test kits. Stratified by vaccination status, it offers a reliable, accessible clinical diagnosis tool.

Area of Science:

  • Infectious Diseases
  • Clinical Diagnostics
  • Public Health

Background:

  • Clinical diagnosis of COVID-19 in Japan relies on symptoms and close contact history, lacking objectivity.
  • Current symptom-based diagnosis for coronavirus disease 2019 (COVID-19) needs enhancement for reliability, especially in high-risk populations.

Purpose of the Study:

  • To develop and validate a symptom-based diagnostic algorithm for COVID-19.
  • Stratify the algorithm by vaccination status to improve diagnostic accuracy for individuals with high-risk exposure.

Main Methods:

  • Retrospective, single-center study in Japan (April 2021-May 2022).
  • Developed a predictive algorithm comparing symptoms of COVID-19 positive and negative individuals with high-risk exposure.
  • Stratified analysis based on vaccination status.

Main Results:

  • The combination of fever, sore throat, and cough showed 100% specificity but low sensitivity for COVID-19 diagnosis.
  • Among vaccinated individuals, sore throat and cough were key indicators; fever was more predictive in unvaccinated individuals.
  • The developed algorithm achieved 65.3% sensitivity and 88.5% specificity, comparable to rapid antigen tests.

Conclusions:

  • The symptom-based algorithm provides a reliable, objective method for clinical COVID-19 diagnosis.
  • This tool can facilitate rapid and accessible diagnosis in resource-limited or high-demand settings.
  • Vaccination status is a crucial factor influencing symptom presentation and diagnostic indicators for COVID-19.